Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017910 · ClinicalTrials.gov registry record
Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients
A clinical trial, sponsored by Sonavex.
- Terminated
- Registry status
- 17
- Enrollment target
NCT04017910 is a clinical trial that was terminated before completion, run by Sonavex. The registered enrollment target is 17 participants.
The verdict
NCT04017910 was terminated before completion, sponsored by Sonavex.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis access.
Interventions
- DEVICE EchoMark/EchoSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2021-05-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04017910
The ClinicalTrials.gov registry entry for NCT04017910 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonavex, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EchoMark/EchoSure is the first listed.
NCT04017910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04017910 about?
NCT04017910 is a clinical study titled "Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients". This is a two stage, prospective, multi-center study to evaluate the EchoMark and EchoSure devices in patients undergoing peripheral arteriovenous fistula creation for hemodialysis access.
What is the current status of trial NCT04017910?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2019-12-02. Estimated completion is 2021-05-12.
What interventions are being tested in trial NCT04017910?
The interventions under investigation include: EchoMark/EchoSure (DEVICE).
Who is sponsoring clinical trial NCT04017910?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.